4.7 Review

Protein kinase B: signalling roles and therapeutic targeting

Journal

CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 65, Issue 1, Pages 113-127

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00018-007-7274-9

Keywords

Protein kinase B; Akt; insulin; apoptosis; cell survival; cell cycle; cancer; diabetes

Funding

  1. Biotechnology and Biological Sciences Research Council Funding Source: Medline
  2. Wellcome Trust Funding Source: Medline
  3. Breast Cancer Now [2005NOV41] Funding Source: Medline

Ask authors/readers for more resources

The serine/threonine kinase, protein kinase B (PKB, also known as Akt), is activated by a wide array of growth factors and insulin. PKB is a central player in the regulation of metabolism, apoptosis, transcription and the cell-cycle. PKB exists as three isoforms (alpha, beta and gamma) that may have unique as well as common functions within the cell. Deregulation of PKB is associated with several human diseases, including cancer, diabetes and schizophrenia. These findings underscore the medical relevance of the PKB pathway and make PKB an attractive drug target for the treatment of diseases that exhibit abnormal PKB signalling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available